Montilla-Uzcátegui Verónica, Araujo-Unda Hilarión, Daza-Restrepo Anilú, Sáenz-Farret Michel, Micheli Federico
*Parkinson's Disease and Movement Disorders Unit, Neurology Department, Hospital de Clínicas "José de San Martín," Buenos Aires University, Buenos Aires, Argentina; and †Neurology Unit, Movement Disorders Department, Instituto Autónomo Hospital Universitario de Los Andes, Los Andes University, Mérida, Venezuela.
Clin Neuropharmacol. 2016 Sep-Oct;39(5):262-4. doi: 10.1097/WNF.0000000000000164.
This study aimed to report the case of a patient with paroxysmal nonkinesigenic dyskinesias and Fahr syndrome who had a marked response to carbamazepine.
We present the case of a 57-year-old female patient with episodes of paroxysmal choreoathetoid dyskinesias in the oromandibular region and distal region of upper and lower extremities, with fluctuating dystonic postures in the same distribution; duration was variable ranging from 30 minutes to 3 hours. Laboratory studies were consistent with primary hyperparathyroidism with bilateral brain calcifications.
Treatment with low doses of carbamazepine was successful.
